Skip to main content
HR 6348 114th Congress House

To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.

Introduced: November 17, 2016 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2016
Referred to the House Committee on Energy and Commerce.
Nov 17, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 17, 2016

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)

 Related & companion bills 1
  • HR 6347 Related bill To extend for one year the program for priority review to encourage treatments for rare pediatric diseases.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6348: To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-6348/
MLA
"H.R. 6348: To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-6348/.
Bluebook (legal)
H.R. 6348, 114th Cong. (2026), https://openamerica.io/bill/114-HR-6348/.
Markdown link
[H.R. 6348: To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.](https://openamerica.io/bill/114-HR-6348/)
Report a problem